SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-034182
Filing Date
2024-11-08
Accepted
2024-11-08 14:51:24
Documents
71
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q krbp20240930_10q.htm   iXBRL 10-Q 1507339
2 EXHIBIT 31.1 ex_716814.htm EX-31.1 12312
3 EXHIBIT 31.2 ex_716815.htm EX-31.2 12392
4 EXHIBIT 32.1 ex_716816.htm EX-32.1 5238
5 EXHIBIT 32.2 ex_716817.htm EX-32.2 5293
  Complete submission text file 0001437749-24-034182.txt   6699882

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA krbp-20240930.xsd EX-101.SCH 51915
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE krbp-20240930_cal.xml EX-101.CAL 34188
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE krbp-20240930_def.xml EX-101.DEF 385944
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE krbp-20240930_lab.xml EX-101.LAB 300965
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krbp-20240930_pre.xml EX-101.PRE 415138
74 EXTRACTED XBRL INSTANCE DOCUMENT krbp20240930_10q_htm.xml XML 1191784
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

IRS No.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39619 | Film No.: 241440034
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)